Metabolomics

, Volume 10, Issue 6, pp 1113–1120 | Cite as

Application of gas chromatography mass spectrometry (GC–MS) in conjunction with multivariate classification for the diagnosis of gastrointestinal diseases

  • Michael Cauchi
  • Dawn P. Fowler
  • Christopher Walton
  • Claire Turner
  • Wenjing Jia
  • Rebekah N. Whitehead
  • Lesley Griffiths
  • Claire Dawson
  • Hao Bai
  • Rosemary H. Waring
  • David B. Ramsden
  • John O. Hunter
  • Jeffrey A. Cole
  • Conrad Bessant
Original Article

Abstract

Gastrointestinal diseases such as irritable bowel syndrome, Crohn’s disease (CD) and ulcerative colitis are a growing concern in the developed world. Current techniques for diagnosis are often costly, time consuming, inefficient, of great discomfort to the patient, and offer poor sensitivities and specificities. This paper describes the development and evaluation of a new methodology for the non-invasive diagnosis of such diseases using a combination of gas chromatography mass spectrometry (GC–MS) and chemometrics. Several potential sample matrices were tested: blood, breath, faeces and urine. Faecal samples provided the only statistically significant results, providing discrimination between CD and healthy controls with an overall classification accuracy of 85 % (78 % specificity; 93 % sensitivity). Differentiating CD from other diseases proved more challenging, with overall classification accuracy dropping to 79 % (83 % specificity; 68 % sensitivity). This diagnostic performance compares well with the gold standard technique of colonoscopy, suggesting that GC–MS may have potential as a non-invasive screening tool.

Keywords

Gastrointestinal diseases Irritable bowel syndrome Crohn’s disease Ulcerative colitis Gas chromatography mass spectrometry Partial least squares discriminant analysis 

Notes

Acknowledgements

We gratefully acknowledge the Wellcome Trust for funding the work (Project 080238/Z/06/Z).

Supplementary material

11306_2014_650_MOESM1_ESM.docx (33 kb)
Supplementary material 1 (DOCX 32 kb)

References

  1. Abraham, C., & Cho, J. H. (2009). Inflammatory bowel disease. New England Journal of Medicine, 361(21), 2066–2078.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Angriman, I., Scarpa, M., et al. (2007). Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clinica Chimica Acta, 381(1), 63–68.CrossRefGoogle Scholar
  3. Barker, M., & Rayens, W. (2003). Partial least squares for discrimination. Journal of Chemometrics, 17(3), 166–173.CrossRefGoogle Scholar
  4. Brereton, R. G. (2003). Chemometrics: Data analysis for the laboratory and chemical plant. Chichester: Wiley.CrossRefGoogle Scholar
  5. Brereton, R. G. (2009). Chemometrics for pattern recognition. Chichester: Wiley.CrossRefGoogle Scholar
  6. Campbell, M. J., & Machin, D. (1999). Medical statistics: A common sense approach. Chichester: Wiley.Google Scholar
  7. de Jong, S. (1993). SIMPLS: An alternative approach to partial least squares regression. Chemometrics and Intelligent Laboratory Systems, 18(3), 251–263.CrossRefGoogle Scholar
  8. Farrell, R. J., Banerjee, S., et al. (2001). Recent advances in inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences, 38(1), 33–108.CrossRefPubMedGoogle Scholar
  9. Fefferman, D. S., & Farrell, R. J. (2005). Endoscopy in inflammatory bowel disease: Indications, surveillance and use in clinical practice. Clinical Gastroenterology and Hepatology, 3, 11–24.CrossRefPubMedGoogle Scholar
  10. Hagan, M. T., Demuth, H. B., et al. (1996). Neural network design. Boston: International Thompson Publishing.Google Scholar
  11. Hotelling, H. (1931). The generalization of student’s ratio. Annals of Mathematics and Statistics, 2(3), 360–378.CrossRefGoogle Scholar
  12. Kussmann, M., Raymond, F., et al. (2006). OMICS-driven biomarker discovery in nutrition and health. Journal of Biotechnology, 124(4), 758–787.CrossRefPubMedGoogle Scholar
  13. Langhorst, J., Kühle, C. A., et al. (2007). MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: Diagnostic accuracy and patient acceptance. Inflammatory Bowel Diseases, 13(8), 1001–1008.CrossRefPubMedGoogle Scholar
  14. Lavine, B., & Workman, J. J. (2004). Chemometrics. Analytical Chemistry, 76(12), 3365–3372.CrossRefPubMedGoogle Scholar
  15. Lechner, M., Colvin, H. P., et al. (2005). Headspace screening of fluid obtained from the gut during colonoscopy and breath analysis by proton transfer reaction–mass spectrometry: A novel approach in the diagnosis of gastro-intestinal diseases. International Journal of Mass Spectrometry, 243(2), 151–154.CrossRefGoogle Scholar
  16. Makidono, C., Mizuno, M., et al. (2004). Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (cd55) in patients with active ulcerative colitis. Journal of Laboratory and Clinical Medicine, 143(3), 152–158.CrossRefPubMedGoogle Scholar
  17. Manes, G., Imbesi, V., et al. (2009). Use of colonoscopy in the management of patients with Crohn’s disease: Appropriateness and diagnostic yield. Digestive and Liver Disease, 41(9), 653–658.CrossRefPubMedGoogle Scholar
  18. Mendoza, J. L., & Abreu, M. T. (2009). Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique, 33(Supplement 3), S158–S173.CrossRefPubMedGoogle Scholar
  19. Moum, B., Ekbom, A., et al. (1997). Inflammatory bowel disease: Re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut, 40, 328–332.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Nakamura, R. M., & Barry, M. (2001). Serologic markers in inflammatory bowel disease (IBD). Medical Laboratory Observations, 33, 8–15.Google Scholar
  21. Nakamura, R. M., Matsutani, M., et al. (2003). Advances in clinical laboratory tests for inflammatory bowel disease. Clinica Chimica Acta, 335(1–2), 9–20.CrossRefGoogle Scholar
  22. Otto, M. (1999). Chemometrics: statistics and computer applications in analytical chemistry. Germany: Wiley.Google Scholar
  23. Papadakis, K. A., & Targen, S. A. (1999). Current theories of the causes of inflammatory bowel disease. Gastroenterology Clinics of North America, 28, 283–296.CrossRefPubMedGoogle Scholar
  24. Pasikanti, K. K., Esuvaranathan, K., et al. (2010). Noninvasive urinary metabonomic diagnosis of human bladder cancer. Journal of Proteome Research, 9(6), 2988–2995.CrossRefPubMedGoogle Scholar
  25. Pasikanti, K. K., Ho, P. C., et al. (2008). Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography B, 871(2), 202–211.CrossRefGoogle Scholar
  26. Peakman, T. C., & Elliott, P. (2008). The UK Biobank sample handling and storage validation studies. International Journal of Epidemiology, 37(suppl 1), i2–i6.CrossRefPubMedGoogle Scholar
  27. Rahman, Q., & Schmeisser, G. (1990). Characterization of the speed of convergence of the trapezoidal rule. Numerische Mathematik, 57(1), 123–138.CrossRefGoogle Scholar
  28. Sattlecker, M., Bessant, C., et al. (2010). Investigation of support vector machines and Raman spectroscopy for lymph node diagnostics. Analyst, 135(5), 895–901.CrossRefPubMedGoogle Scholar
  29. Schoepfer, A. M., Dehlavi, M.-A., et al. (2013). Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. American Journal of Gastroenterology, 108(11), 1744–1753.CrossRefPubMedGoogle Scholar
  30. Seidman, E., & Deslandres, C. (1997). Pitfalls in the diagnosis and management of pediatric IBD. Lancaster: Kluwer Academic Publishing.Google Scholar
  31. Stange, E. F., Travis, S. P. L., et al. (2008). European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn’s and Colitis, 2(1), 1–23.CrossRefPubMedGoogle Scholar
  32. Tomasi, G., van den Berg, F., et al. (2004). Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data. Journal of Chemometrics, 18(5), 231–241.CrossRefGoogle Scholar
  33. van den Berg, R., Hoefsloot, H., et al. (2006). Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics, 7(1), 142.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Vella, M., Masood, M. R., et al. (2007). Surgery for ulcerative colitis. The Surgeon, 5(5), 355–362.Google Scholar
  35. von Stein, P., Kouznetsov, N., et al. (2007). P032 multi-gene approach to discriminate for ulcerative colitis, Crohn’s disease and irritable bowel syndrome. Journal of Crohn’s and Colitis Supplements, 1(1), 12.CrossRefGoogle Scholar
  36. von Stein, P., Lofberg, R., et al. (2008). Multigene analysis can discriminate between ulcerative colitis, Crohn’s disease, and irritable bowel syndrome. Gastroenterology, 134(7), 1869–1881.CrossRefGoogle Scholar
  37. Walton, C., Fowler, D. P., et al. (2013). Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflammatory Bowel Diseases, 19(10), 2069–2078.CrossRefPubMedGoogle Scholar
  38. Westerhuis, J., Hoefsloot, H., et al. (2008). Assessment of PLSDA cross validation. Metabolomics, 4(1), 81–89.CrossRefGoogle Scholar
  39. Wiklund, S., Johansson, E., et al. (2007). Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry, 80(1), 115–122.CrossRefPubMedGoogle Scholar
  40. Wold, S., Esbensen, K., et al. (1987). Principal component analysis. Chemometrics and Intelligent Laboratory Systems, 2(1–3), 37–52.CrossRefGoogle Scholar
  41. Zweig, M. H., & Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry, 39(4), 561–577.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Michael Cauchi
    • 1
  • Dawn P. Fowler
    • 2
  • Christopher Walton
    • 2
  • Claire Turner
    • 3
  • Wenjing Jia
    • 4
  • Rebekah N. Whitehead
    • 4
  • Lesley Griffiths
    • 4
  • Claire Dawson
    • 5
  • Hao Bai
    • 6
  • Rosemary H. Waring
    • 4
  • David B. Ramsden
    • 4
  • John O. Hunter
    • 5
  • Jeffrey A. Cole
    • 4
  • Conrad Bessant
    • 7
  1. 1.Centre for Biomedical Engineering, School of Engineering, Building 63Cranfield UniversityBedfordshireUK
  2. 2.School of Applied SciencesCranfield UniversityBedfordshireUK
  3. 3.The Department of Life, Health and Chemical SciencesOpen UniversityMilton KeynesUK
  4. 4.School of BiosciencesUniversity of BirminghamBirminghamUK
  5. 5.Gastroenterology Research UnitAddenbrooke’s HospitalCambridgeUK
  6. 6.School of Electronic, Electrical and Computer EngineeringUniversity of BirminghamBirminghamUK
  7. 7.School of Biological and Chemical SciencesQueen Mary University of LondonLondonUK

Personalised recommendations